<DOC>
	<DOCNO>NCT01762111</DOCNO>
	<brief_summary>The woman fertility decrease age closely link ovarian reserve , number available eggs ovary . Therefore , important evaluate ovarian reserve specific marker well prediction response vitro fertilization treatment well rate pregnancy . Until , lot clinical criterion ( age , duration infertility , number antral follicle ) biological ( FSH , Oestradiol , Inhibin B , EFFORT test , number egg retrieval day ) suggest help estimation ovarian reserve . Since couple year , anti-müllerian hormone ( AMH ) recognize one best ovarian reserve marker , correspond number antral follicle , sensitive predictive . Moreover , In-Vitro Fertilization , anti-müllerian hormone provide weak respond stimulation reverse , risk excessive responds ( hyperstimulation ) . To choose gonadotropin dos administrate ( stimulation ovarian hormone ) In-Vitro Fertilization protocol , need know anti-müllerian hormone dosage . However , anti-müllerian hormone recognize evaluate quantity available eggs ovary , role determine quality egg still discuss . The goal study verify serum anti-müllerian hormone ( blood ) good indicator quality reserve ovarian evaluate impact anti-müllerian hormone rate pregnancy rate implantation rate , stimulate In-Vitro Fertilization protocol .</brief_summary>
	<brief_title>AMH Pregnancy Rate Age During Stimulate In-Vitro Fertilization Protocol</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>All infertile patient age 18 43 year Patients prescription stimulate InVitro Fertilization cycle Presence endocrine disease : diabetes , hyperprolactinemia , abnormal thyroidstimulating hormone ( TSH ) Cushing syndrome Renal hepatic impairment know</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Anti-Mullerian Hormone</keyword>
	<keyword>In-Vitro fertilization</keyword>
</DOC>